HCV infection is an exponentially growing health burden worldwide, with an estimated 170 million people infected. Although therapies for HCV are continually improving, there remain a considerable proportion of patients who do not achieve viral eradication and develop liver disease. Natural killer (NK) cells are crucial for T-cell activation and are one of the first-line sentinel cell responders to viral infection. A recent explosion in studies exploring the role of NK cells in HCV infection has yielded important mechanistic information and intriguing potential therapeutic options for HCV infection. This review provides a general overview of normal NK cell function and outlines some of the important mechanisms characterizing the immune interplay between NK cells and HCV infection.
References
1.
PoynardT., BedossaP., OpolonP.Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet1997; 349: 825–832.
2.
HeX.S., RehermannB., Lopez-LabradorF.X.Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A1999; 96: 5692–5697.
MalmbergK.J., BrycesonY.T., CarlstenM.NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy. Cancer Immunol Immunother2008; 57: 1541–1552.
7.
GerosaF., Baldani-GuerraB., NisiiC., MarchesiniV., CarraG., TrinchieriG.Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med2002; 195: 327–333.
8.
PiccioliD., SbranaS., MelandriE., ValianteN.M.Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med2002; 195: 335–341.
9.
RauletD.H.Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol2004; 5: 996–1002.
10.
CheentK., KhakooS.I.Natural killer cells and hepatitis C: action and reaction. Gut2011; 60: 268–278.
11.
CoradoJ., ToroF., RiveraH., BiancoN.E., DeibisL., De SanctisJ.B.Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection. Clin Exp Immunol1997; 109: 451–457.
12.
AhlenstielG., EdlichB., HogdalL.J.Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. Gastroenterology2011; 141: 1231–1239.
13.
HarrisonR.J., EttorreA., LittleA.M., KhakooS.I.Association of NKG2A with treatment for chronic hepatitis C virus infection. Clin Exp Immunol2010; 161: 306–314.
14.
GerosaF., GobbiA., ZorziP.The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol2005; 174: 727–734.
CooperM.A., FehnigerT.A., TurnerS.C.Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood2001; 97: 3146–3151.
17.
ChanA., HongD.L., AtzbergerA.CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J Immunol2007; 179: 89–94.
18.
BjörkstromN.K., RieseP., HeutsF.Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood2010; 116: 3853–3864.
19.
Lopez-VergèsS., MilushJ.M., PandeyS.CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood2010; 116: 3865–3874.
20.
DohertyD.G., NorrisS., Madrigal-EstebasL.The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol1999; 163: 2314–2321.
21.
WisseE., van't NoordendeJ.M., van der MeulenJ., DaemsW.T.The pit cell: description of a new type of cell occurring in rat liver sinusoids and peripheral blood. Cell Tissue Res1976; 173: 423–435.
22.
LassenM.G., LukensJ.R., DolinaJ.S., BrownM.G., HahnY.S.Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state. J Immunol2010; 184: 2693–2701.
23.
MelhemA., MuhannaN., BisharaA.Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J Hepatol2006; 45: 60–71.
24.
GaoB., RadaevaS., JeongW.I.Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis. Expert Rev Gastroenterol Hepatol2007; 1: 173–180.
25.
MorishimaC., PaschalD.M., WangC.C.Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing. Hepatology2006; 43: 573–580.
BrycesonY.T., LjunggrenH.G., LongE.O.Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood2009; 114: 2657–2666.
28.
LeeS.H., YunS., PiaoZ.H.Suppressor of cytokine signaling 2 regulates IL-15-primed human NK cell function via control of phosphorylated Pyk2. J Immunol2010; 185: 917–928.
29.
Golden-MasonL., Madrigal-EstebasL., McGrathE.Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut2008; 57: 1121–1128.
30.
SiegalF.P., KadowakiN., ShodellM.The nature of the principal type 1 interferon-producing cells in human blood. Science1999; 284: 1835–1837.
31.
TrinchieriG., SantoliD.Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med1978; 147: 1314–1333.
32.
PerussiaB., FanningV., TrinchieriG.A leukocyte subset bearing HLA-DR antigens is responsible for in vitro alpha interferon production in response to viruses. Nat Immun Cell Growth Regul1985; 4: 120–137.
33.
DolganiucA., ChangS., KodysK.Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J Immunol2006; 177: 6758–6768.
34.
SzaboG., ChangS., DolganiucA.Altered innate immunity in chronic hepatitis C infection: cause or effect?Hepatology2007; 46: 1279–1290.
35.
KhakooS.I., CarringtonM.KIR and disease: a model system or system of models?Immunol Rev2006; 214: 186–201.
36.
VilchesC., ParhamP.KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol2002; 20: 217–251.
37.
BoyingtonJ.C., SunP.D.A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol Immunol2002; 38: 1007–1021.
38.
FaridiR.M., AgrawalS.Killer immunoglobulin-like receptors (KIRs) and HLA-C allorecognition patterns implicative of dominant activation of natural killer cells contribute to recurrent miscarriages. Hum Reprod2011; 26: 491–497.
39.
Seich al BasatenaN.K., MacnamaraA., VineA.M.KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. PLoS Pathog2011; 7: e1002270.
40.
KhakooS.I., ThioC.L., MartinM.P.HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science2004; 305: 872–874.
41.
OhiraM., IshiyamaK., TanakaY.Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice. J Clin Invest2009; 119: 3226–3235.
42.
RalainirinaN., PoliA., MichelT.Control of NK cell functions by CD4+CD25+ regulatory T cells. J Leukoc Biol2007; 81: 144–153.
43.
LanierL.L.Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol2008; 9: 495–502.
44.
ZarifeM.A., ReisE.A., CarmoT.M.Increased frequency of CD56bright NK-cells, CD3-CD16+CD56- NK-cells and activated CD4+ T-cells or B-cells in parallel with CD4+CDC25high T-cells control potentially viremia in blood donors with HCV. J Med Virol2009; 81: 49–59.
45.
MaX., ChowJ.M., GriG.The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med1996; 183: 147–157.
46.
CooperM.A., ColonnaM., YokoyamaW.M.Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Rep2009; 10: 1103–1110.
FengS., GoodrichN.P., Bragg-GreshamJ.L.Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant2006; 6: 783–790.
49.
LucinP., JonjicS., MesserleM., PolicB., HengelH., KoszinowskiU.H.Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J Gen Virol1994; 75: 101–110.
50.
HeiseM.T., VirginH.W.IVThe T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J Virol1995; 69: 904–909.
51.
MacMickingJ., XieQ.W., NathanC.Nitric oxide and macrophage function. Annu Rev Immunol1997; 15: 323–350.
52.
OrangeJ.S., BironC.A.An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol1996; 156: 1138–1142.
53.
WangS.H., HuangC.X., YeL.Natural killer cells suppress full cycle HCV infection of human hepatocytes. J Viral Hepat2008; 15: 855–864.
54.
CocciaE.M., UzeG., PellegriniS.Negative regulation of type I interferon signaling: facts and mechanisms. Cell Mol Biol2006; 52: 77–87.
55.
HartO.M., Athie-MoralesV., O'ConnorG.M., GardinerC.M.TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J Immunol2005; 175: 1636–1642.
56.
QiuF., ManiarA., DiazM.Q., ChapovalA.I., MedvedevA.E.Activation of cytokine-producing and antitumor activities of natural killer cells and macrophages by engagement of Toll-like and NOD-like receptors. Innate Immun2011; 17: 375–387.
57.
Aste-AmezagaM., D'AndreaA., KubinM., TrinchieriG.Cooperation of natural killer cell stimulatory factor/ interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell Immunol1994; 156: 480–492.
58.
EbiharaT., AzumaM., OshiumiH.Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation. J Exp Med2010; 207: 2675–2687.
59.
MatsumotoM., FunamiK., TanabeM.Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol2003; 171: 3154–3162.
60.
McCartneyS., VermiW., GilfillanS.Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells. J Exp Med2009; 206: 2967–2976.
61.
FoyE., LiK., SumpterR.Jr.Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci U S A2005; 102: 2986–2991.
62.
LooY.M., OwenD.M., LiK.Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A2006; 103: 6001–6006.
LeeP.T., BenlaghaK., TeytonL., BendelacA.Distinct functional lineages of human V(alpha)24 natural killer T cells. J Exp Med2002; 195: 637–641.
65.
KantoT., HayashiN.Innate immunity in hepatitis C virus infection: Interplay among dendritic cells, natural killer cells and natural killer T cells. Hepatol Res2007; 37Suppl 3: S319–S326.
66.
AmadeiB., UrbaniS., CazalyA.Activation of natural killer cells during acute infection with hepatitis C virus. Gastroenterology2010; 138: 1536–1545.
67.
Golden-MasonL., CoxA.L., RandallJ.A., ChengL., RosenH.R.Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro.Hepatology2010; 52: 1581–1589.
68.
PelletierS., DrouinC., BedardN., KhakooS.I., BruneauJ., ShoukryN.H.Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses. J Hepatol2010; 53: 805–816.
69.
BonorinoP., RamzanM., CamousX.Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. J Hepatol2009; 51: 458–467.
70.
AlterG., JostS., RihnS.Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance. J Hepatol2011; 55: 278–288.
71.
MiyagiT., TakeharaT., NishioK.Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection. J Hepatol2010; 53: 424–430.
72.
KnappS., WarshowU., HegazyD.Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus. Hepatology2010; 51: 1168–1175.
73.
RomeroV., AzocarJ., ZunigaJ.Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in hepatitis C virus infection outcome. Mol Immunol2008; 45: 2429–2436.
74.
KimA.Y., KuntzenT., TimmJ.Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes. Gastroenterology2011; 140: 686–696.
DessoukiO., KamiyaY., NagahamaH.Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: reversion by antiviral treatment. Biochem Biophys Res Commun2010; 393: 331–337.
77.
KawarabayashiN., SekiS., HatsuseK.Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology2000; 32: 962–969.
78.
CrottaS., StillaA., WackA.Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med2002; 195: 35–41.
79.
BonavitaM.S., FrancoA., ParoliM.Normalization of depressed natural killer activity after interferon-alpha therapy is associated with a low frequency of relapse in patients with chronic hepatitis C. Int J Tissue React1993; 15: 11–16.
80.
PárG., RukavinaD., PodackE.R.Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection. J Hepatol2002; 37: 514–522.
81.
YoonJ.C., ShiinaM., AhlenstielG., RehermannB.Natural killer cell function is intact after direct exposure to infectious hepatitis C virions. Hepatology2009; 49: 12–21.
82.
DüesbergU., SchneidersA.M., FliegerD., InchauspeG., SauerbruchT., SpenglerU.Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C. J Hepatol2001; 35: 650–657.
83.
RosenH.R., DohertyD.G., Madrigal-EstebasL., O'FarrellyC., Golden-MasonL.Pretransplantation CD56(+) innate lymphocyte populations associated with severity of hepatitis C virus recurrence. Liver Transpl2008; 14: 31–40.
84.
MeierU.C., OwenR.E., TaylorE.Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J Virol2005; 79: 12365–12374.
85.
JinushiM., TakeharaT., TatsumiT.Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J Immunol2003; 171: 5423–5429.
86.
NattermannJ., FeldmannG., AhlenstielG., LanghansB., SauerbruchT., SpenglerU.Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut2006; 55: 869–877.
87.
De MariaA., FogliM., MazzaS.Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur J Immunol2007; 37: 445–455.
88.
CrottaS., BrazzoliM., PiccioliD., ValianteN.M., WackA.Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection. J Hepatol2010; 52: 183–190.
89.
AbelM., SeneD., PolS.Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection. Hepatology2006; 44: 1607–1616.
90.
AccapezzatoD., FrancavillaV., ParoliM.Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest2004; 113: 963–972.
91.
TsengC.T., KlimpelG.R.Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med2002; 195: 43–49.
92.
EidA.J., BrownR.A., PayaC.V., RazonableR.R.Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation2007; 84: 511–516.
93.
FaragM.M., WeigandK., EnckeJ., MomburgF.Activation of natural killer cells by hepatitis C virus particles in vitro.Clin Exp Immunol2011; 165: 352–362.
94.
JinushiM., TakeharaT., TatsumiT.Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J Immunol2004; 173: 6072–6081.
95.
JinushiM., TakeharaT., TatsumiT.Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J Immunol2004; 173: 6072–6081.
96.
JinushiM., TakeharaT., TatsumiT.Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J Hepatol2005; 43: 1013–1020.
97.
AndradeC.F., WaddellT.K., KeshavjeeS., LiuM.Innate immunity and organ transplantation: the potential role of toll-like receptors. Am J Transplant2005; 5: 969–975.
98.
AhlenstielG., TiterenceR.H., KohC.Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology2010; 138: 325–335.
99.
NattermannJ., NischalkeH.D., HofmeisterV.The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am J Pathol2005; 166: 443–453.
100.
SèneD., LevasseurF., AbelM.Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines. PLoS Pathog2010; 6: e1001184.
101.
EbiharaT., MasudaH., AkazawaT.Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection. Int Immunol2007; 19: 1145–1155.
102.
WenC., HeX., MaH.Hepatitis C virus infection downregulates the ligands of the activating receptor NKG2D. Cell Mol Immunol2008; 5: 475–478.
103.
OlivieroB., VarchettaS., PaudiceE.Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology2009; 137: 1151–1160.
104.
LaydenT.J., MikaB., WileyT.E.Hepatitis C kinetics: mathematical modeling of viral response to therapy. Semin Liver Dis2000; 20: 173–183.
105.
Vidal-CastiñeiraJ.R., Lopez-VazquezA., Diaz-PenaR.Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection. J Virol2010; 84: 475–481.
106.
CarneiroV.L., LemaireD.C., BendichoM.T.Natural killer cell receptor and HLA-C gene polymorphisms among patients with hepatitis C: a comparison between sustained virological responders and non-responders. Liver Int2010; 30: 567–573.
107.
Golden-MasonL., BambhaK.M., ChengL.Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C. Hepatology2011; 54: 1559–1569.
108.
LeeS., WatsonM.W., FlexmanJ.P., ChengW., HammondT., PriceP.Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alpha and ribavirin therapy. J Med Virol2010; 82: 568–574.
109.
CharltonM., WiesnerR.Natural history and management of hepatitis C infection after liver transplantation. Semin Liver Dis2004; 24Suppl 2: 79–88.
110.
BerenguerM.What determines the natural history of recurrent hepatitis C after liver transplantation?J Hepatol2005; 42: 448–456.
111.
VarchettaS., OlivieroB., Francesca DonatoM.Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation. J Hepatol2009; 50: 314–322.
112.
de AriasA.E., HaworthS.E., BelliL.S.Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. Liver Transpl2009; 15: 390–399.
RadaevaS., SunR., JarugaB., NguyenV.T., TianZ., GaoB.Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology2006; 130: 435–452.
115.
HanvesakulR., SpencerN., CookM.Donor HLA-C genotype has a profound impact on the clinical outcome following liver transplantation. Am J Transplant2008; 8: 1931–1941.
116.
ParhamP.Immunology. NK cells lose their inhibition. Science2004; 305: 786–787.
117.
TranT.H., MiddletonD., DohlerB.Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival. Am J Transplant2009; 9: 1674–1678.
